REG - Mobeus Inc&Gwth 4 - Interim Management Statement

Mobeus Income & Growth 4 VCTAnnouncement

15/11/2023 15:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231115:nRSO5916Ta&default-theme=true

RNS Number : 5916T  Mobeus Income & Growth 4 VCT PLC  15 November 2023

MOBEUS INCOME & GROWTH 4 VCT PLC

("the Company")

LEI:  213800IFNJ65R8AQW943

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

 

Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement
for the quarter ended 30 September 2023. The statement also includes relevant
financial information between the end of the period and the date of this
statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

                                                                                           At 30            At 30 June 2023

September 2023

                (unaudited)
                                                                                           (unaudited)
 Net assets attributable to shareholders                                                   £86.63 million   £84.23 million
 Shares in issue                                                                           110,556,762      110,556,762

 Net asset value (NAV) per share                                                           78.36 pence      76.19 pence
 Cumulative dividends paid                                                                 158.20 pence     158.20 pence
 Cumulative Total return (net asset value basis) per share since inception                 236.52 pence     234.39 pence

The NAV per share has decreased by 2.17 pence in the quarter (an increase of
2.85% from the opening NAV per share).

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.40 million into
Mable Therapy, a digital health platform for speech therapy and counselling
for children and young adults.

 

On 3 August 2023, the Company completed a new investment of £0.39 million
into Branchspace Limited, a digital retailing consultancy and software
provider to the aviation and travel industry.

 

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.33 million was made into
Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.12 million was made into
Orri, an intensive day care provider for adults with eating disorders.

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

There has been no activity post-quarter.

 

SHARE BUYBACK AFTER THE PERIOD END

 

On 17 October 2023, the Company purchased 525,821 of its own ordinary
shares at a price of 66.68 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

DIVIDEND DECLARED AFTER THE PERIOD END

 

On 5 October 2023, a second interim dividend of 6.00 pence per share in
respect of the year ending 31 December 2023 was declared and was paid on 8
November 2023 to all Shareholders whose names were on the register on 13
October 2023. Payment of this interim dividend will reduce NAV per share
(shown above) to 72.36 pence and increase cumulative dividends paid to 164.20
pence per share.

 

DIVIDEND INVESTMENT SCHEME ("DIS")

 

 On 8 November 2023, 1,515,451 shares were allotted through the DIS during
the period at a price of 70.19 pence per share.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period
and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZELFFXFLLFBV